Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Sirtris Pharmaceuticals, Inc. (SIRT)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Sirtris Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Sirtris Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is SIRT. The reporting company's CIK number is 1388775.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $2,457,665.
The total value of stock option exercises since 2005 is $228,395.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2008-05-29||Westphal Christoph H (President and CEO)||Option Ex||181,796||.76||138,164|
|2008-05-28||Brannelly Paul (VP Finance, Treasurer)||Option Ex||14,643||.42||6,150|
|2008-05-27||Elliott Peter (Senior VP, Head of Development)||Option Ex||95,832||.76||72,832|
|2008-03-05||Westphal Christoph H (President and CEO)||Sale||6,810||11.55||78,648|
|2008-03-04||Westphal Christoph H (President and CEO)||Sale||8,690||11.53||100,204|
|2008-02-06||Brannelly Paul (VP Finance, Treasurer)||Sale||6,547||12.30||80,541|
|2008-01-24||Brannelly Paul (VP Finance, Treasurer)||Sale||13,096||12.81||167,772|
|2008-01-22||Jirousek Michael (Senior VP, Research)||Sale||20,000||12.57||249,646|
|2008-01-08||Westphal Christoph H (President and CEO)||Sale||40,000||13.93||557,225|
|2007-11-30||Schimmel Paul||Option Ex||26,785||.42||11,249|
Insider trading activities including stock purchases, stock sales, and option exercises of SIRT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sirtris Pharmaceuticals, Inc. (symbol SIRT, CIK number 1388775) see the Securities and Exchange Commission (SEC) website.